Diacerein Reduces Mean Hemoglobin A1c Levels in T2DM

Share this content:
Diacerein Reduces Mean Hemoglobin A1c Levels in T2DM
Diacerein Reduces Mean Hemoglobin A1c Levels in T2DM

FRIDAY, Aug. 25, 2017 (HealthDay News) -- An immune-modulator anti-inflammatory drug, diacerein, reduces the mean hemoglobin A1c (HbA1c) levels in patients with type 2 diabetes, according to a study published online Aug. 17 in Diabetes Care.

Claudia R.L. Cardoso, Ph.D., from the Universidade Federal do Rio de Janeiro, and colleagues conducted a randomized trial involving 84 patients with HbA1c between 7.5 and 9.5 percent. Eighty-four participants were randomized to 48-week treatment with placebo (41 patients) or diacerein 100 mg/day (43 patients).

The researchers found that, compared with placebo, diacerein reduced HbA1c by 0.35 percent in the intention-to-treat analysis and by 0.41 percent in the per-protocol analysis. At the 24th week of treatment, the peak of effect occurred (−0.61 and −0.78 percent, respectively); the effect attenuated toward nonsignificant differences at the 48th week. Diacerein had no significant effect in other efficacy and safety measures. Sixty-five percent of patients receiving diacerein had diarrhea, and treatment was interrupted in 16 percent. Insulin dosage was reduced in seven patients in the diacerein group, while dosage was increased for 10 patients in the placebo group.

"The drug was well tolerated and may be indicated as adjunct treatment in patients with type 2 diabetes, particularly in those with osteoarthritis," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Florida Teen First Human Case of Another Mosquito-Borne Virus

Florida Teen First Human Case of Another Mosquito-Borne ...

First documented case of Keystone infection in a human

70 Sickened So Far in Salmonella-Tainted Melon Outbreak

70 Sickened So Far in Salmonella-Tainted Melon Outbreak

Illnesses reported in Illinois, Indiana, Kentucky, Michigan, Missouri, Ohio, and Tennessee

AAFP Still Recommends CRC Screening From Age 50 to 75

AAFP Still Recommends CRC Screening From Age 50 ...

Despite ACS change to start screening from age 45 years, AAFP agrees with USPSTF recommendation

is free, fast, and customized just for you!




Already a member?

Sign In Now »